Page last updated: 2024-12-06

n-chlorosuccinimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-Chlorosuccinimide (NCS) is a white, crystalline solid that is commonly used as a chlorinating agent in organic chemistry. It is synthesized by reacting succinimide with chlorine gas in the presence of a base, such as sodium hydroxide. NCS is a powerful electrophilic reagent that can be used to introduce a chlorine atom into a variety of organic molecules, including alkanes, alkenes, and aromatic compounds. It is particularly useful for chlorinating allylic and benzylic positions, as well as for the formation of chlorohydrins. NCS is also used in the synthesis of various pharmaceuticals and other fine chemicals. Its importance lies in its ability to introduce chlorine selectively and efficiently, making it a valuable tool for organic synthesis. Researchers study NCS to understand its reactivity, selectivity, and potential applications in various areas, such as drug discovery and materials science.'

N-chlorosuccinimide : A five-membered cyclic dicarboximide compound having a chloro substituent on the nitrogen atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID31398
CHEMBL ID2107513
CHEBI ID53203
SCHEMBL ID72
MeSH IDM0065253

Synonyms (72)

Synonym
ai3-52304
brn 0113915
caswell no. 807
einecs 204-878-8
1-chloro-2,5-pyrrolidinedione
succinic acid, imide, n-chloro-
epa pesticide chemical code 077301
hsdb 5407
nsc 8748
succinimide, n-chloro-
succinic n-chloroimide
128-09-6
2, 1-chloro-
nsc8748
nsc-8748
chlorosuccinimide
succinchlorimide
succinochlorimide
n-chlorosuccinimide
wln: t5vnvtj bg
2,5-pyrrolidinedione, 1-chloro-
inchi=1/c4h4clno2/c5-6-3(7)1-2-4(6)8/h1-2h
NCS ,
n-chlorosuccinimide, 98%
1-chloropyrrolidine-2,5-dione
CHEBI:53203 ,
1-chloro-2,5-pyrrolidine-dione
AKOS000121131
n-chloro-succinimide
dtxcid0022199
tox21_301368
dtxsid2042199 ,
NCGC00255991-01
cas-128-09-6
5-21-09-00543 (beilstein handbook reference)
succinchlorimide [nf]
0fwp306h7x ,
unii-0fwp306h7x
FT-0600487
PS-3219
CHEMBL2107513
c4h4clno2
succinchlorimide [mart.]
n-chlorosuccinimide [mi]
succinchlorimide [hsdb]
BP-21326
BBL027530
SCHEMBL72
n-chlorosucinimide
n-chlorosuccinirnide
1-chloro-pyrrolidine-2,5-dione
n-chlorosuccinimid e
n-chlorosuccinimid
1-chloro-pyrrolidine-2, 5-dione
n-clorosuccinimide
n-chloro succinimide
n-chorosuccinimide
n-chlorosuc-cinimide
n-chlorsuccinimide
n -chlorosuccinimide
n-chlorosuccinic acid imide
1-chloro-2,5 pyrrolidinedione
Q-201455
mfcd00005511
n chloro succinimide
F0001-0394
Q286192
BCP27379
EN300-25969
STL194270
AMY31063
D78048

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Physostigmine (10(-7) M), at a concentration that did not alter resting tension, mimicked NCS-induced effects on contractile responses to ACh and EFS with the greater degree of shift in the respective dose-response curves."( Chemical oxidant potentiates electrically and acetylcholine-induced contraction in rat trachea: possible involvement of cholinesterase inhibition.
Aikawa, T; Nakazawa, H; Ohkawara, Y; Ohrui, T; Sasaki, H; Sekizawa, K; Takishima, T; Yamauchi, K, 1991
)
0.28
" Both the time-course and dose-response studies in human lung fibroblasts revealed that the induction of HGF messenger RNA (mRNA) and protein occurred in parallel, indicating that the mechanism existed at the steady-state mRNA level."( Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts.
Abe, T; Kikuchi, T; Mitsuhashi, H; Nakamura, T; Nukiwa, T; Satoh, K; Tominaga, Y; Yaekashiwa, M, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
pyrrolidinone
dicarboximideAn imide in which the two acyl substituents on nitrogen are carboacyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
progesterone receptorHomo sapiens (human)Potency121.97200.000417.946075.1148AID1346784
estrogen nuclear receptor alphaHomo sapiens (human)Potency138.00600.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (89)

TimeframeStudies, This Drug (%)All Drugs %
pre-199033 (37.08)18.7374
1990's23 (25.84)18.2507
2000's13 (14.61)29.6817
2010's18 (20.22)24.3611
2020's2 (2.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.70 (24.57)
Research Supply Index4.52 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index77.46 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other91 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]